HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
HTG Molecular Diagnostics (HTGM) - Cash on Hand
Cash on Hand as of March 2023 : $6.56 M
According to HTG Molecular Diagnostics
's latest financial reports the company has $6.56 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
HTG Molecular Diagnostics - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $12.21 M | -44.35% |
| 2021-12-31 | $21.94 M | -23.53% |
| 2020-12-31 | $28.69 M | -13.12% |
| 2019-12-31 | $33.02 M | 6.16% |
| 2018-12-31 | $31.11 M | 212.12% |
| 2017-12-31 | $9.96 M | -15.61% |
| 2016-12-31 | $11.81 M | -62.49% |
| 2015-12-31 | $31.49 M | 771.63% |
| 2014-12-31 | $3.61 M | 99.05% |
| 2013-12-31 | $1.81 M | -75.19% |
| 2012-12-31 | $7.31 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.17 B | 2,490.66% | 🇺🇸 USA |
 Affimed
AFMD | $80.59 M | 1,128.01% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | $25.45 M | 287.79% | 🇺🇸 USA |